Bilirubin(Total) QVET
510(k) K942999
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK942999 | Date2 Dec 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CIG
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1110
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
A bilirubin (total or direct) test system is a device intended to measure the levels of bilirubin (total or direct) in plasma or serum. Measurements of bilirubin levels are used in the diagnosis and treatment of liver, hemolytic hematological, and metabolic disorders.
The device is supplied by Prisma Systems and received FDA 510(k) clearance under K number K942999 with product code CIG. It is classified as a Class II device under regulation number 862.1110 for clinical chemistry applications.
Other devices from Prisma Systems
Questions
AI-generated answers, 22 Sep 2026
What is the Bilirubin(Total) QVET test system used for?
The Bilirubin(Total) QVET test system is intended to measure the levels of bilirubin (total or direct) in plasma or serum. These measurements are used in the diagnosis and treatment of liver, hemolytic hematological, and metabolic disorders, as stated in the device description.
How is the Bilirubin(Total) QVET test system supplied and what is its regulatory status?
The device is supplied by Prisma Systems and received FDA 510(k) clearance under K number K942999 with product code CIG. It is classified as a Class II device under regulation number 862.1110 for clinical chemistry applications, based on the authorization and specification data provided.
What type of clearance did the Bilirubin(Total) QVET receive and when was it granted?
The Bilirubin(Total) QVET received traditional FDA 510(k) clearance, as indicated by the clearance_type field. The decision date was December 2, 1994, following receipt of the submission on June 23, 1994, according to the dates in the device data.